newsfilter
← Latest News
Business Wire·

AVROBIO to Present at Two Upcoming Investor Conferences in March

AVROBIO, Inc. (NASDAQ:AVRO), a leading clinical-stage gene therapy company with a shared purpose to free people from a lifetime of genetic disease, today announced that members of its senior management team are scheduled to participate in two upcoming i